
Gemibine 1000mg Injection
Marketer
Intas Pharmaceuticals Ltd
Salt Composition
Gemcitabine (1000mg)
Overview Gemibine 1000mg Injection
Gemzar 1000mg Injection is indicated for the management of various cancers, including non-small cell lung, breast, pancreatic, bladder, and ovarian cancers. Administration is strictly by intravenous injection under the supervision of a healthcare professional. Dosage frequency and amount are determined individually by your physician based on your specific condition and may be adjusted. Adhere precisely to your doctor's prescribed regimen; incorrect usage or overdose can result in severe adverse events. Therapeutic effects may not be immediately apparent, potentially taking weeks or months; discontinue only upon your doctor's instruction. Common side effects encompass nausea, vomiting, anorexia, alopecia, and thrombocytopenia. This medication can suppress blood cell production (red and white blood cells), raising infection risk. Regular blood work monitoring is crucial, including assessments of blood cell counts, cardiac function, liver health, and uric acid levels. Prior to initiating treatment, disclose any pre-existing cardiac, hepatic, or renal conditions, and any concurrent medications, especially anti-infectives, to your physician. Significant drug interactions are possible; provide your doctor with a complete medication list. Use during pregnancy or breastfeeding is contraindicated. Employing effective contraception is vital for both partners throughout the treatment period to prevent conception.
Primary Ingredients of Gemibine 1000mg Injection
No text provided. Please provide the text you wish me to rephrase.
Uses of Gemibine 1000mg Injection
Lung cancer (non-small cell type), breast cancer, pancreatic cancer, bladder cancer, and ovarian cancer.
Major Benefits of Gemibine 1000mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Gemibine 1000mg Injection:
- Nausea
- Vomiting
- Loss of appetite
- Hair loss
- Low blood platelets
- Allergic reaction
- Breathlessness
- Decreased white blood cell count
- Increased liver enzymes
- Anemia (low number of red blood cells)
- Flu-like symptoms
- Blood in urine
- Skin rash
- Protein in urine
How to use Gemibine 1000mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Gemibine 1000mg Injection works:
Gemcitabine's 1000mg injectable formulation disrupts cancer cell DNA and RNA synthesis by replacing essential components. This action halts tumor growth and proliferation.
SAFETY ADVICE
AlcoholUNSAFE
Alcohol consumption may increase drowsiness when using Gemcitabine 1000mg Injection.
PregnancyCONSULT YOUR DOCTOR
Administering 1000mg Gemibine injections during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. In exceptional circumstances involving life-threatening conditions, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingUNSAFE
Administration of 1000mg Gemibine injections is contraindicated while breastfeeding due to potential infant toxicity. Evidence indicates a risk of harm to the nursing infant.
DrivingUNSAFE
Administration of Gemcitabine 1000mg Injection can induce drowsiness, blurred vision, and dizziness. Driving is prohibited if these side effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Gemibine 1000mg Injection's use in individuals with renal impairment. Physician consultation is necessary. Assessment of kidney function is recommended prior to, and during, treatment with this medication.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of 1000mg Gemibine injections to individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Gemibine 1000mg Injection :
NA
Facts to Know About Gemibine 1000mg Injection
Label | Value |
---|---|
Chemical Category | Cytosine Analog |
Developing Habits | No. |
Treatment Category | Cancer Medications |
Behavior Class | Metabolic Inhibitors |